PD-L1 inhibits T cell responses by activating the downstream signaling pathway of the PD-1 receptor, reducing T cell activity and promoting apoptosis, thereby inhibiting T cell responses and leading to tumor immune escape. The gene discussed is CD274; the disease is neoplasm.